Antimicrobial susceptibility of bacteremic vancomycin-resistant Enterococcus faecium to eravacycline, omadacycline, lipoglycopeptides, and other comparator antibiotics: Results from the 2019/2020 Nationwide Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART).

[1]  F. Xue,et al.  Real-time PCR for the rapid detection of vanA, vanB and vanM genes. , 2020, Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi.

[2]  I. Morrissey,et al.  In Vitro Activity of Eravacycline against Gram-Positive Bacteria Isolated in Clinical Laboratories Worldwide from 2013 to 2017 , 2019, Antimicrobial Agents and Chemotherapy.

[3]  Yu Zhou,et al.  Molecular characterization of vancomycin-resistant enterococci isolated from a hospital in Beijing, China. , 2019, Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi.

[4]  M. Dowzicky,et al.  Antimicrobial susceptibility of Gram-negative and Gram-positive bacteria collected from Eastern Europe: Results from the Tigecycline Evaluation and Surveillance Trial (T.E.S.T.), 2011-2016. , 2019, Journal of global antimicrobial resistance.

[5]  Ronald N. Jones,et al.  Temporal and Geographic Variation in Antimicrobial Susceptibility and Resistance Patterns of Enterococci: Results From the SENTRY Antimicrobial Surveillance Program, 1997–2016 , 2019, Open forum infectious diseases.

[6]  M. Huband,et al.  Antimicrobial Activity of Omadacycline Tested against Clinical Bacterial Isolates from Hospitals in Mainland China, Hong Kong, and Taiwan: Results from the SENTRY Antimicrobial Surveillance Program (2013 to 2016) , 2019, Antimicrobial Agents and Chemotherapy.

[7]  Luísa Peixe,et al.  Update on prevalence and mechanisms of resistance to linezolid, tigecycline and daptomycin in enterococci in Europe: Towards a common nomenclature. , 2018, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

[8]  M. Pfaller,et al.  Five-Year Summary of In Vitro Activity and Resistance Mechanisms of Linezolid against Clinically Important Gram-Positive Cocci in the United States from the LEADER Surveillance Program (2011 to 2015) , 2017, Antimicrobial Agents and Chemotherapy.

[9]  Hsin-Yi Lin,et al.  Effect of Daptomycin Dose on the Outcome of Vancomycin-Resistant, Daptomycin-Susceptible Enterococcus faecium Bacteremia , 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[10]  N. Ledeboer,et al.  Resistance Mechanisms, Epidemiology, and Approaches to Screening for Vancomycin-Resistant Enterococcus in the Health Care Setting , 2016, Journal of Clinical Microbiology.

[11]  Hsin-Yi Lin,et al.  Daptomycin versus linezolid for treatment of vancomycin-resistant enterococcal bacteremia: systematic review and meta-analysis , 2014, BMC Infectious Diseases.

[12]  K. Hegstad,et al.  Cluster of linezolid-resistant Enterococcus faecium ST117 in Norwegian hospitals , 2014, Scandinavian journal of infectious diseases.

[13]  B. Bozdoğan,et al.  [In vitro activity of linezolid and dalbavancin against vancomycin-resistant enterococci]. , 2012, Mikrobiyoloji bulteni.

[14]  Chun-Eng Liu,et al.  Trends in Susceptibility of Vancomycin-Resistant Enterococcus faecium to Tigecycline, Daptomycin, and Linezolid and Molecular Epidemiology of the Isolates: Results from the Tigecycline In Vitro Surveillance in Taiwan (TIST) Study, 2006 to 2010 , 2012, Antimicrobial Agents and Chemotherapy.

[15]  H. Barkema,et al.  Diagnostic Accuracy Assessment of Sensititre and Agar Disk Diffusion for Determining Antimicrobial Resistance Profiles of Bovine Clinical Mastitis Pathogens , 2011, Journal of Clinical Microbiology.

[16]  M. Castanheira,et al.  ZAAPS programme results for 2016: an activity and spectrum analysis of linezolid using clinical isolates from medical centres in 42 countries , 2018, The Journal of antimicrobial chemotherapy.

[17]  M. Rybak,et al.  Evaluation of tedizolid against Staphylococcus aureus and enterococci with reduced susceptibility to vancomycin, daptomycin or linezolid. , 2016, The Journal of antimicrobial chemotherapy.